Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal Cancers [Research Articles]
This article is highlighted in the In This Issue feature, p. 920
Source: Cancer Discovery - Category: Cancer & Oncology Authors: Bialucha, C. U., Collins, S. D., Li, X., Saxena, P., Zhang, X., Dürr, C., Lafont, B., Prieur, P., Shim, Y., Mosher, R., Lee, D., Ostrom, L., Hu, T., Bilic, S., Rajlic, I. L., Capka, V., Jiang, W., Wagner, J. P., Elliott, G., Veloso, A., Piel, J. C Tags: Research Articles Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Drugs & Pharmacology | Genetics | Kidney Cancer | Ovarian Cancer | Ovaries | Study | Toxicology | Urology & Nephrology